Cargando…
Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)
BACKGROUND: Physical activity (PA) is a non-pharmacological approach to alleviate symptom burden and improve health-related quality of life (HrQoL) in cancer patients (pts). Whether pts with myeloproliferative neoplasms (MPN) PA behavior changes due to symptom burden and/or knowledge of the putative...
Autores principales: | Felser, Sabine, Rogahn, Julia, le Coutre, Philipp, Al-Ali, Haifa Kathrin, Schulze, Susann, Muegge, Lars-Olof, Gruen, Julia, Geissler, Jan, Kraze-Kliebhahn, Veronika, Junghanss, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846799/ https://www.ncbi.nlm.nih.gov/pubmed/36686756 http://dx.doi.org/10.3389/fonc.2022.1056786 |
Ejemplares similares
-
Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)
por: Felser, Sabine, et al.
Publicado: (2023) -
Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)
por: Felser, Sabine, et al.
Publicado: (2022) -
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)
por: Jotschke, Sabrina, et al.
Publicado: (2022) -
Osho - Insights on sex
por: Nagaraj, Anil Kumar Mysore
Publicado: (2013) -
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
por: Heinicke, Thomas, et al.
Publicado: (2021)